INTS vs MDLZ · $7.7M cap vs P/E 30, rev $38.54B
Intensity Therapeutics, Inc. Common stock (INTS) versus Mondelez International Inc (MDLZ) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Mondelez International Inc (MDLZ) is a confectioners company listed on NASDAQ.
INTS does not have a complete income-statement cache yet.
Latest reported MDLZ revenue for 2025-12-31 was $38.54B. Net income was $2.45B. Revenue was up 5.8% from 2024-12-31 to 2025-12-31. MDLZ currently screens at market cap $78.12B and trailing P/E 30.1.
INTS currently screens at market cap $7.7M. MDLZ currently screens at market cap $78.12B and trailing P/E 30.1.
Not investment advice. Open the INTS and MDLZ stock pages for the full models.
Not investment advice.